MEGAN STUTHEIT: Open Payments
NPI 1972155232 · OWENSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 19 payments from 10 companies in 2025. Trend: 2023 $201 · 2024 $371 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $84 |
| ABBVIE INC. | 4 | $84 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| Lilly USA, LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: INGREZZA, VRAYLAR, Wegovy, Rybelsus, QULIPTA, MOUNJARO, Dexcom G6 Transmitter, ELIQUIS.
Industry payments across MO — which companies pay providers there.
